A novel complex mutation of the OTC (ornithine transcarbamylase) gene in a Malaysian pedigree by A. S. Khoo et al.
HUMAN MUTATION  M utation and Polymorphism Report #76 (1999) Online
Mutation and Polymorphism Report
Authors: A.S.B. Khoo1 , P. Balraj1 , A. Rachedi2 , C.N. Chin3 ,  and L. Volpi1
Affiliations: 1 Division of Molecular Pathology, Institute for Medical Research, 50588 Kuala Lumpur,
Malaysia; 2 Centre for Gene Analysis and Technology, Faculty of Life Science, National
University of Malaysia, 43000 Bangi, Malaysia (Current Address:  Department of Biochemistry,
The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong);
3 Department of Pediatrics, Kuantan Hospital, Kuantan, Malaysia
Corresponding Author Address and E-mail:
Dr. Alan Khoo, Division of Molecular Pathology, Institute for
Medical Research, Jalan Pahang, 50588 Kuala Lumpur,
Malaysia
Phone: +(603)-4402421/4402423
Fax: +(603)-2934114
E-mail:  alankhoo@imr.gov.my
Title : A novel complex mutation of the OTC (ornithine transcarbamylase) gene in a Malaysian pedigree
Keywords:
ornithine transcarbamylase, OTC, indel mutation, urea cycle, infant, newborn
Species: Human
Change is: mutation
Gene/Locus
Name: ornithine carbamoyltransferase (ornithine transcarbamylase)
Symbol: OTC
Genbank accession number:K02100
OMIM accession number: 311250
Locus specific database: http://www.peds.umn.edu/otc
Chromosomal location: Xp21.1
Inheritance: X-linked
Mutation / polymorphism name
Nucleotide change–Systematic name:c.813 indel AG>C
Amino acid change–Trivial name: stop 288
Mutation / polymorphism type: indel mutation, frameshift
Polymorphism frequency:
Detection method: Direct DNA Sequencing
Detection conditions: Primers: 5'-ttactgtcccatgaagttatttaacc-3'
               5'-ggaattaatgaacctgagagagcat-3'
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Standard 30 cycle PCR, annealing temperature 55 C
Diagnosis method developed: Mutation disrupts normal MnlI restriction site
Evidence for existence and effect of mutation:
Yes No Don’t know
1. Base change found on repeat PCR sample X
2. Base change segregates or appears with trait X
3. Base change affects conserved residue X
4. Expression analysis supports hypothesis for causation X
5. Normals tested (50 required) X
Ancillary data
1. Haplotype association :
2. Ethnic background/Population association : Malay
3. Geographic association : Malaysia
4. Frequency (of mutation) in population:
5. Clinical phenotype of proband : Severe neonatal hyperammonemia
6. Homologous allele (if recessive trait):
7. PIC:  (if microsatellite)
8. Other:
9. Present in HGMD listing:
(http://www.cf.ac.uk/uwcm/mg/hgmd0.html)
Yes: No: X
Comments
The propositus, presented with clinical symptoms at day 2 of life and had a strong family history of
multiple early neonatal deaths in males.  PCR and direct sequencing using primer sequences of Matsuura et
al. (1993) revealed an innocent polymorphism (L101F) (Tuchman and Plante, 1995) and a complex
mutation consisting of deletions  of A and G of nucleotides 813 and 814 respectively in exon 8 (the third
nucleotide of codon 271 and the first nucleotide of codon 272) which were replaced by an insertion of C (
c.813 indel  AG > C).  The indel mutation caused a frame shift which resulted in a stop codon (TGA)
occurring 17 amino acids downstream the first mutant codon.  The frameshift also resulted in the 17 amino
acid (DRRRKSGSRLSKVTRLQ) sequence being different from corresponding wild type sequence of the
human OTC (EEEKKKRLQAFQGYQVT) (Hata et al., 1988). The predicted  amino acid sequence would
result in a truncated protein of 287 amino acid (the wild type being 355 aa).  (The mutation was named
based on the cDNA sequence of the OTC precursor protein (Horwich et al., 1984)  beginning from position
136 of the mRNA sequence Gen Bank Acc No. K02100 ie. the same numbering system used in HGMD).
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